LATEST
Wed, Nov 4, 2026
Loading weather...
Markets

Mirum Pharmaceuticals Reports Q3 2026 Financial Results and Raises Full-Year Sales Guidance

Mirum Pharmaceuticals, Inc. reported total revenue of $185.7 million for the quarter ended September 30, 2026, compared ...

Mirum Pharmaceuticals, Inc. reported total revenue of $185.7 million for the quarter ended September 30, 2026, compared to $133.0 million for the quarter ended September 30, 2025. Total operating expenses were $245.5 million for the quarter ended September 30, 2026 compared to $1

SOURCE: Nasdaq
ORIGINAL REPORT: Click here
DHALLO EDITORIAL STATUS: Aggregated & reviewed
Have feedback on this article?Report error or suggestion

Read More from Markets

Soybeans Fade Another Export Sale with Midday Losses on Tuesday

Soybeans are trading with 3 to 8 cent losses across most contracts on Tuesday. T...

Read Article »

Cocoa Prices Fall on Signs of Abundant Supplies

December ICE NY cocoa (CCZ26 ) is down -33 (-0.61%) today, and ICE London cocoa ...

Read Article »

Stronger Indian Sugar Output Hammers Prices

March NY world sugar #11 (SBH27 ) is down -0.67 (-3.52%) today, and December Lon...

Read Article »
Return to Front Page

5 minutes. The news that matters.

Get the most important stories of the day, without having to browse hundreds of articles.